162 related articles for article (PubMed ID: 1999047)
1. Xanthine oxidase inhibition does not limit canine infarct size.
Werns SW; Grum CM; Ventura A; Hahn RA; Ho PP; Towner RD; Fantone JC; Schork MA; Lucchesi BR
Circulation; 1991 Mar; 83(3):995-1005. PubMed ID: 1999047
[TBL] [Abstract][Full Text] [Related]
2. The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion.
Kinsman JM; Murry CE; Richard VJ; Jennings RB; Reimer KA
J Am Coll Cardiol; 1988 Jul; 12(1):209-17. PubMed ID: 3379207
[TBL] [Abstract][Full Text] [Related]
3. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.
Puett DW; Forman MB; Cates CU; Wilson BH; Hande KR; Friesinger GC; Virmani R
Circulation; 1987 Sep; 76(3):678-86. PubMed ID: 3621527
[TBL] [Abstract][Full Text] [Related]
4. Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs.
Reimer KA; Jennings RB
Circulation; 1985 May; 71(5):1069-75. PubMed ID: 3838707
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of oxypurinol pretreatment in stunned, reperfused canine myocardium.
Holzgrefe HH; Gibson JK
Cardiovasc Res; 1989 Apr; 23(4):340-50. PubMed ID: 2590915
[TBL] [Abstract][Full Text] [Related]
6. Myocardial infarct size-limiting effect of ischemic preconditioning was not attenuated by oxygen free-radical scavengers in the rabbit.
Iwamoto T; Miura T; Adachi T; Noto T; Ogawa T; Tsuchida A; Iimura O
Circulation; 1991 Mar; 83(3):1015-22. PubMed ID: 1999006
[TBL] [Abstract][Full Text] [Related]
7. Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts.
Akizuki S; Yoshida S; Chambers DE; Eddy LJ; Parmley LF; Yellon DM; Downey JM
Cardiovasc Res; 1985 Nov; 19(11):686-92. PubMed ID: 3841027
[TBL] [Abstract][Full Text] [Related]
8. Oxypurinol limits myocardial infarct size in closed chest dogs without pretreatment.
Matsuki T; Shirato C; Cohen MV; Downey JM
Can J Cardiol; 1990 Apr; 6(3):123-9. PubMed ID: 2340442
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium.
Charlat MI; O'Neill PG; Egan JM; Abernethy DR; Michael LH; Myers ML; Roberts R; Bolli R
Am J Physiol; 1987 Mar; 252(3 Pt 2):H566-77. PubMed ID: 3826401
[TBL] [Abstract][Full Text] [Related]
10. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs.
Richard VJ; Murry CE; Jennings RB; Reimer KA
Circulation; 1988 Aug; 78(2):473-80. PubMed ID: 3396182
[TBL] [Abstract][Full Text] [Related]
11. A useful canine model of ischemic myocardium with coronary retrograde flow diversion, and its application for the study of allopurinol on myocardial infarct size.
Motoe M; Yoshida S
Jpn Circ J; 1991 May; 55(5):490-9. PubMed ID: 2062000
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol: kinetics, inhibition of xanthine oxidase activity, and protective effect in ischemic-reperfused canine heart as studied by cardiac microdialysis.
Kuzmin AI; Tskitishvili OV; Serebryakova LI; Kapelko VI; Majorova IV; Medvedev OS
J Cardiovasc Pharmacol; 1995 Apr; 25(4):564-71. PubMed ID: 7596124
[TBL] [Abstract][Full Text] [Related]
13. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.
Werns SW; Shea MJ; Mitsos SE; Dysko RC; Fantone JC; Schork MA; Abrams GD; Pitt B; Lucchesi BR
Circulation; 1986 Mar; 73(3):518-24. PubMed ID: 3004782
[TBL] [Abstract][Full Text] [Related]
14. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage.
Das DK; Engelman RM; Clement R; Otani H; Prasad MR; Rao PS
Biochem Biophys Res Commun; 1987 Oct; 148(1):314-9. PubMed ID: 2823807
[TBL] [Abstract][Full Text] [Related]
15. Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion.
Horwitz LD; Fennessey PV; Shikes RH; Kong Y
Circulation; 1994 Apr; 89(4):1792-801. PubMed ID: 8149545
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy.
Baldus S; Müllerleile K; Chumley P; Steven D; Rudolph V; Lund GK; Staude HJ; Stork A; Köster R; Kähler J; Weiss C; Münzel T; Meinertz T; Freeman BA; Heitzer T
Free Radic Biol Med; 2006 Oct; 41(8):1282-8. PubMed ID: 17015175
[TBL] [Abstract][Full Text] [Related]
17. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs.
Uraizee A; Reimer KA; Murry CE; Jennings RB
Circulation; 1987 Jun; 75(6):1237-48. PubMed ID: 3568330
[TBL] [Abstract][Full Text] [Related]
18. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
Mizumura T; Nithipatikom K; Gross GJ
Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
[TBL] [Abstract][Full Text] [Related]
19. Oxypurinol as an inhibitor of xanthine oxidase-catalyzed production of superoxide radical.
Spector T
Biochem Pharmacol; 1988 Jan; 37(2):349-52. PubMed ID: 2829916
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of xanthine oxidase by 4-hydroxy-6-mercaptopyrazolo[3,4-d]pyrimidine.
Spector T; Hall WW; Porter DJ; Lambe CU; Nelson DJ; Krenitsky TA
Biochem Pharmacol; 1989 Dec; 38(23):4315-20. PubMed ID: 2557043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
